While Nvidia's (NVDA) record high on Monday — the stock has since retreated in Tuesday trading — pushes the tech sector and hopes for the AI chip industry higher, perhaps there are still some opportunities for investors that lie outside of artificial intelligence.

Alger Director of Market Strategy Brad Neuman sits down with the Catalysts team in-studio to talk about the three categories or investment themes he is seeing outside of AI: homebuilders, drug developers, and alternative asset managers.

"Structurally, we're short homes in America... maybe 2 million homes. So there's a supply-demand imbalance," Neuman tells Seana Smith. "So it's an attractive market from that perspective. And cyclically mortgage rates are kind of elevated relative to the general interest rate picture."

In the homebuilder category, Neuman names Builders FirstSource (BLDR), NVR, Inc. (NVR), and Trex Company (TREX).

Neuman also makes the case for structural-cyclical dynamics in the biotech and pharmaceutical space:

"The pipeline is growing, so it's a growth industry. That said there was an inventory overhang after COVID and the volumes have waned over the past couple of years. But we think they're on the upswing. And next year is setting up to be a normal year, or perhaps even better than that."

He names Repligen (RGEN) and Danaher (DHR) for this category.

Lastly, Neuman turns to alternative asset management firms, and lists Blue Owl Capital (OWL), StepStone Group (STEP), and Hamilton Lane (HLNE) among potential opportunities.

To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

This post was written by Luke Carberry Mogan.